A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns

In a retrospective analysis of 457 Mayo Clinic patients (median age 72 years) with chronic myelomonocytic leukemia (CMML; proliferative 38%; CMML-2 15%), overall survival (OS), calculated from time of diagnosis, was not differentially affected by treatment exposure to i) neither cytotoxic nor non-c...

Descrición completa

Detalles Bibliográficos

Principais autores:	Muhammad Yousuf, Priyansh Faldu, Maymona Abdelmagid, Fnu Aperna, Saubia Fathima, Ali Khalid A. Alsugair, Clifford M. Csizmar, Terra L. Lasho, Abhishek A. Mangaonkar, Kaaren K. Reichard, Rong He, Animesh Pardanani, Naseema Gangat, Mrinal M. Patnaik., Ayalew Tefferi
Formato:	Artigo
Idioma:	Inglês
Publicado:	Ferrata Storti Foundation 2025-10-01
Series:	Haematologica
Acceso en liña:	https://haematologica.org/article/view/12942
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!